Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft‐tissue sarcomas

Cancer

Volumn 66, Issue 5, 1990, Pages 862-867

  Borden, Ernest C ^a   Amato, David A ^b   Edmonson, John H ^c   Ritch, Paul S ^d   Shiraki, Masanori ^e  

^a UNIVERSITY OF WISCONSIN   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MAYO CLINIC   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; VINDESINE;

ARTICLE; BONE MARROW SUPPRESSION; CARDIOTOXICITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; COMPARATIVE STUDY; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; HUMAN; MALE; MIDDLE AGE; NAUSEA; RANDOMIZED CONTROLLED TRIALS; REMISSION INDUCTION; SARCOMA; SOFT TISSUE NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; VINDESINE; VOMITING;

EID: 0025150176     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19900901)66:5<862::AID-CNCR2820660509>3.0.CO;2-R     Document Type: Article

References (14)

1. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas
2. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcoma: A randomized comparative trial. A Phase III, Southwest Oncology Group study (7613)
3. Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC)
4. Effect of desacetyl vinblastine amide (DVA) against human sarcomas heterotransplanted in nude mice
5. Adriamycin chemotherapy—efficacy, safety and pharmacologic basis of an intermittent single high dosage schedule
6. An overview of studies with adriamycin (NSC‐123127) in the United States (Part 3)
7. Metastatic sarcomas: Chemotherapy with adriamycin, cyclophosphamide and methotrexate alternating with actinomycin D, DTIC, and vincristine
8. A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin D, and cyclophosphamide for advanced sarcoma
9. Recommendations for clinical protocol development and definition of therapeutic response for soft tissue sarcomas: Adult Intergroup Soft Tissue Sarcoma Committee
10. The randomization and stratification of patients to clinical trials
11. Regression models and life‐tables (with discussion)
12. Cyclophosphamide versus ifosfamide: Final report of a randomized Phase II trial in adult soft tissue sarcomas
13. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma